Alterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report) was the target of a large growth in short interest in May. As of May 15th, there was short interest totalling 124,200 shares, a growth of… [+2187 chars]...
Read moreAlterity Therapeutics (NASDAQ:ATHE – Get Free Report) and Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contras… [+6150 chars]...
Read moreAlterity Therapeutics (NASDAQ:ATHE – Get Free Report) and Talphera (NASDAQ:TLPH – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two co… [+4861 chars]...
Read moreDublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "Multiple System Atrophy (MSA or Shy-Drager Syndrome or Multi-System Degeneration) - Global Clinical Trials Review, 2025" clinical trials has been added t… [+4721 chars]...
Read more